New data on canine osteosarcoma
n honor of National Pet Cancer Awareness Month, Nationwide pet insurance wants to help #curepetcancer with new insights on this old-dog disease.
In a continuing effort to educate pet owners about the prevalence, detection and treatment of pet cancer, Nationwide is partnering with the Animal Cancer Foundation (ACF) to increase awareness and raise funds to fight the number one disease-related killer of dogs and cats. Last year, Nationwide received more than 75,000 pet insurance claims for cancer diagnosis and treatment in pets (a 10% increase from the year prior), making cancer-related conditions one of the most common types of medical claims.
During the month of November, Nationwide will donate $5 to the Animal Cancer Foundation, up to $30,000, for every photo, story or statistic shared on Facebook, Twitter and Instagram using #CurePetCancer (for further information, go here).
Let's take a closer look at recent data on osteosarcoma:
And a broader scope:
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
Podcast CE: A Surgeon’s Perspective on Current Trends for the Management of Osteoarthritis, Part 1
May 17th 2024David L. Dycus, DVM, MS, CCRP, DACVS joins Adam Christman, DVM, MBA, to discuss a proactive approach to the diagnosis of osteoarthritis and the best tools for general practice.
Listen
